<DOC>
	<DOCNO>NCT00520507</DOCNO>
	<brief_summary>OBJECTIVES : Primary Objective : To assess objective ( polysomnographic ) change sleep quality introduction olanzapine treatment patient depression . Secondary Objectives : To assess subjective change sleep quality parameter different stage introduction olanzapine treatment , longitudinally , correlate change measure illness severity change cognition . STUDY DESIGN : Prospective , double blind , randomize polysomnographic ( PSG ) study patient treatment olanzapine . PSG record do three time throughout study : start olanzapine augmentation ( baseline ) , day 3 5 ( acute ) day 28 31 ( chronic ) . PSG complete patient ' home portable PSG . Psychiatric scale , subjective sleep quality scale , cognition measurement complete visit .</brief_summary>
	<brief_title>An Investigation Sleep Architecture Consequent Cognitive Changes Olanzapine-Treated Depressed Patients</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>1 . A diagnosis major depressive disorder bipolar disorder type 1 , 2 NOS Diagnostic Statistical Manual Mental Disorders Fourth Edition ( DSMIV ) 2 . Current depressive episode HAMD17 &gt; 15 3 . Males females age18 year ( yr ) 4 . Inpatients outpatients 5 . Female patient childbearing potential must use reliable method contraception negative urine human chorionic gonadotropin ( HCG ) test enrollment 6 . Able understand comply requirement study 7 . Provision write informed consent 1 . Current manic , hypomanic mixed episode , YMRS &gt; 12 2 . Current past diagnosis schizophrenia dementia 3 . Pregnant woman , woman childbearing age , willing use appropriate contraception woman currently nurse 4 . Patient antipsychotic medication 5 . Patients , opinion investigator , pose imminent risk suicide danger self others 6 . Known intolerance lack response olanzapine , judge investigator 7 . Benzodiazepines sleepaids must discontinue prior participation study stable dosage 4 week previous entry study 8 . No change current medication regime ( exclude discontinuation sleep aid antipsychotic medication ) allow 4 week prior first PSG read 9 . Administration depot antipsychotic injection within two dose interval ( depot ) randomization 10 . Substance alcohol dependence enrolment last three month ( except caffeine nicotine dependence ) , define DSMIV criterion 11 . Serious , unstable inadequately treat medical illness judge investigator 12 . History epilepsy uncontrolled seizure 13 . Involvement plan conduct study 14 . Previous enrolment present study 15 . Participation another drug trial within 4 week prior enrolment study long accordance local requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Depression</keyword>
	<keyword>Bipolar Disorder</keyword>
	<keyword>Major</keyword>
</DOC>